ctrl K

AI Score

Unlock

Centessa Pharmaceuticals (CNTA)

AI Score

Unlock

14.62

0.11 (0.76%)

At close: Mar 28, 2025, 12:38 PM

Centessa Pharmaceuticals Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	6.85M	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	130.92K	33.99K	n/a	n/a
Gross Profit	n/a	6.85M	-130.92K	-33.99K	n/a	n/a
Operating Income	-201.06M	-171.28M	-212.26M	-139.31M	-10.44M	-5.05M
Interest Income	14.02M	10.48M	7.03K	2.55K	378.00	5K
Pretax Income	-232.91M	-176.14M	-216.95M	-381.74M	-10.66M	-5.06M
Net Income	-235.76M	-151.09M	-216.21M	-381.85M	-11.04M	-5.28M
Selling & General & Admin	50.81M	53.73M	55.2M	42.97M	1.14M	790K
Research & Development	150.24M	124.41M	155.08M	96.31M	9.3M	4.26M
Other Expenses	n/a	n/a	2.34M	n/a	155K	105K
Operating Expenses	201.06M	178.14M	210.28M	139.28M	10.44M	5.05M
Interest Expense	-10.09M	9.91M	7.03M	2.55M	378K	118K
Selling & Marketing Expenses	n/a	n/a	n/a	42.93M	n/a	n/a
Cost & Expenses	n/a	178.14M	210.28M	139.31M	10.44M	5.05M
Income Tax	2.84M	-25.06M	-747K	113.99K	378K	223K
Shares Outstanding (Basic)	114.47M	96.18M	93.4M	89.99M	142.06M	70.89M
Shares Outstanding (Diluted)	114.47M	96.18M	93.4M	89.99M	142.06M	70.89M
EPS (Basic)	-2.06	-1.57	-2.31	-4.24	-0.08	-0.07
EPS (Diluted)	-2.06	-1.57	-2.31	-4.24	-0.08	-0.07
EBITDA	-201.06M	-166.07M	-212.26M	-379.16M	-10.43M	-4.94M
Depreciation & Amortization	n/a	813.14K	130.92K	33.99K	6K	6K